Theravance Biopharma, Inc. (TBPH) Capital expenditures 2016–2025
Theravance Biopharma, Inc. (TBPH) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$42,000FY2025 · since FY2016: $2.1M → $42,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $42,000 | -87.3% |
| FY2024 | $332,000 | -86.7% |
| FY2023 | $2.5M | +335.0% |
| FY2022 | $572,000 | -83.2% |
| FY2021 | $3.4M | -48.5% |
| FY2020 | $6.6M | +108.3% |
| FY2019 | $3.2M | -56.1% |
| FY2018 | $7.2M | +200.9% |
| FY2017 | $2.4M | +12.7% |
| FY2016 | $2.1M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice